The page is the record's research on the issuer — no analyst, no rating, no view. # SOLVONIS THERAPEUTICS PLC (LSE Main Market: SVNS) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing SOLVONIS THERAPEUTICS PLC is listed on the LSE Main Market under ticker SVNS, ISIN GB00BMD1Z199, LEI 2138005PH7OJRCRPUD88. Its security type is Corporate and its segment is SSQ3. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted. ## The disclosure read The record holds 32 filings in the twelve months from 2025-11-06 to 2026-11-06, on 32 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-06, 0 days before the record date, and is a newswire release. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days, across 892 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days, across 51 issuers. The issuer's 32 filings sit above the exchange median of 29.0 and below the sector median of 42. Its cadence gap of 9 days sits above both medians. Its latency of 0 days sits below both medians. ## Auditor The auditor of record is Kreston Reeves LLP. Its location is not on the record. Auditor changes are not on the record. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted. ## Orderability For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 3 research houses: Singer Capital Markets, Water Tower Research and Turner Pope Investments (TPI) Limited. ## Open research The record holds 1 openly published research note: Water Tower Research, dated 2026-07-13. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth No years are sealed for this issuer, and the market's vintage is not sealed. The market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. ## Sources 12 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/SVNS (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/10776788 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/LSE/SVNS (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://find-and-update.company-information.service.gov.uk/company/10776788/filing-history/MzUyMzcxNjc5NWFkaXF6a2N4/document?format=pdf&download=0 (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://solvonis.com/investor-relations/analyst-coverage (coverage) - https://cdn.smartinsider.com/InternalAnnouncement/pdf/2026/07/13/47627131.pdf (open research) - https://mcp.uk-cm-kg.ai/record/LSE/SVNS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/LSE/SVNS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp